Siemens Healthineers Launches Brain Health Research Portfolio with First Biomarker Assays Now Available Brain-derived, fully automated Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays now available for research use Tarrytown, New York, USA, March 18, 2026 (GLOBE NEWSWIRE) -- Research assays help generate evidence about whether biomarkers can advance disease managementNovel RUO tests can help scientists understand neurological function and disease progressionCollaborative research is underway to translate scientific discovery into actionable e...
Social Media Influence in the Exam Room: National Survey About Medical Testing Reveals Changing Patient Expectations U.S.-based patients’ expectations for testing are changing, potentially at the expense of evidence-based medicine. Patients, feeling empowered by social media, want greater control over test ordering decisions, and some even dismiss doctors’ expertise, mirroring growing mistrust in authority. Tarrytown, New York, Jan. 07, 2026 (GLOBE NEWSWIRE) -- 93% of patients expect their doctor to order a test upon request17% have requested a lab test they learned about from social me...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.